Larvol Delta - CELSCI-to-Launch-FDA-RegistrationEnabling-Phase-3-Conrmatory-Study-to-Bring-Multikine-to-Market-for-Newly-Diagnosed-Head-and-Neck-Cancer

Multikine (leukocyte interleukin injection) - CEL-SCI

https://www.businesswire.com/news/home/20260713392922/en/CEL-SCI-to-Launch-FDA-Registration-Enabling-Phase-3-Confirmatory-Study-to-Bring-Multikine-to-Market-for-Newly-Diagnosed-Head-and-Neck-Cancer

Jul 13, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next